These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 27050204)

  • 1. When Is It Ethical to Withhold Prevention?
    Farley TA
    N Engl J Med; 2016 Apr; 374(14):1303-6. PubMed ID: 27050204
    [No Abstract]   [Full Text] [Related]  

  • 2. [Difficult decision at bedside. Withholding treatment due to costs?].
    Tietze U
    MMW Fortschr Med; 2010 Nov; 152(45):22. PubMed ID: 21319403
    [No Abstract]   [Full Text] [Related]  

  • 3. Dose response: intelligent rationing by physicians is the first step to a health-care system that society can afford.
    Ubel PA
    Sciences (New York); 1999; 39(6):18-23. PubMed ID: 15584152
    [No Abstract]   [Full Text] [Related]  

  • 4. Which newborn infants are too expensive to treat? Camosy and rationing in intensive care.
    Wilkinson D
    J Med Ethics; 2013 Aug; 39(8):502-6. PubMed ID: 23355229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Equity weights in the allocation of health care: the rank-dependent QALY model.
    Bleichrodt H; Diecidue E; Quiggin J
    J Health Econ; 2004 Jan; 23(1):157-71. PubMed ID: 15154692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Summary of Bioethical Prescriptions.
    Kamm F
    J Med Ethics; 2015 Jun; 41(6):488-9. PubMed ID: 24797609
    [No Abstract]   [Full Text] [Related]  

  • 7. Toward a broader view of values in cost-effectiveness analysis of health.
    Menzel P; Gold MR; Nord E; Pinto-Prades JL; Richardson J; Ubel P
    Hastings Cent Rep; 1999; 29(3):7-15. PubMed ID: 10420299
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluating social value: on the intersection of mortality and economics in the distribution of publicly funded medical care.
    Klein DA
    Am J Bioeth; 2011 Jul; 11(7):18-20. PubMed ID: 21745075
    [No Abstract]   [Full Text] [Related]  

  • 9. Application of cost-effectiveness analysis to multiple products: a practical guide.
    Bala MV; Zarkin GA
    Am J Manag Care; 2002 Mar; 8(3):211-8. PubMed ID: 11915971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shifting the focus of rationing discussions.
    Stark M
    Am J Bioeth; 2011 Jul; 11(7):20-2. PubMed ID: 21745076
    [No Abstract]   [Full Text] [Related]  

  • 11. Valuing prevention: discounting health benefits and costs in New Zealand.
    Milne R
    N Z Med J; 2005 May; 118(1214):U1443. PubMed ID: 15886738
    [No Abstract]   [Full Text] [Related]  

  • 12. [Do you reflect before every treatment: what is this patient worth to society?].
    Wiedemann B
    MMW Fortschr Med; 2002 Dec; 144(50):58. PubMed ID: 14610869
    [No Abstract]   [Full Text] [Related]  

  • 13. On the possibility of a bridge between CBA and CEA: comments on a paper by Dolan and Edlin.
    Hansen BO; Hougaard JL; Keiding H; Østerdal LP
    J Health Econ; 2004 Sep; 23(5):887-98. PubMed ID: 15353184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Which newborns are too expensive to treat? A response to Dominic Wilkinson.
    Camosy C
    J Med Ethics; 2013 Aug; 39(8):507-8. PubMed ID: 23355223
    [No Abstract]   [Full Text] [Related]  

  • 15. Is understaffing a unit a form of rationing care?
    Iyer NP; Iben S
    Virtual Mentor; 2012 Nov; 14(11):839-44. PubMed ID: 23351895
    [No Abstract]   [Full Text] [Related]  

  • 16. Cancer drugs offer hope, but at huge expense.
    Berenson A
    N Y Times Web; 2005 Jul; ():A1, C3. PubMed ID: 16075470
    [No Abstract]   [Full Text] [Related]  

  • 17. Against 'Saving Lives': Equal Concern and Differential Impact.
    Chappell RY
    Bioethics; 2016 Mar; 30(3):159-64. PubMed ID: 26132886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measuring the social importance of concentration or dispersion of individual health benefits.
    Rodríguez-Míguez E; Pinto-Prades JL
    Health Econ; 2002 Jan; 11(1):43-53. PubMed ID: 11788981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 'fair innings argument' deserves a fairer hearing! Comments by Alan Williams on Nord and Johannesson.
    Williams A
    Health Econ; 2001 Oct; 10(7):583-5. PubMed ID: 11747042
    [No Abstract]   [Full Text] [Related]  

  • 20. Blood in a time of scarcity.
    Browne A
    Camb Q Healthc Ethics; 2013 Apr; 22(2):159-69. PubMed ID: 23507178
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.